Prostate Cancer
Phase II Clinical Trials of Avicine in Cancer Patients Initiated
Published in Cancer Weekly, September 7th, 1998
The trial marks the first time this type of therapeutic vaccine has been used to study its effect on Prostate Specific Antigen (PSA) levels.
A total of 24 prostate cancer patients are evaluated in the Phase II trial, which monitors quality of life benefits, tumor suppression and PSA levels in treated patients. PRA conducts the multi-center study in the United States to conform with both U.S. and European regulatory approval...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-09-07)
More Articles from Cancer Weekly
- Cancer Gene Therapy (Melanoma)
Ex Vivo and In Vivo Adenovirus-Mediated Gene Therapy Show Promise - Antisense Therapy
P-Glycoprotein Inhibition Sensitizes Leukemic Cells to Chemotherapy - DNA Vaccines
Location, Location, Location: Ear Pinna is the Superior Vaccionation Site - Carcinogenesis
IFN May Decrease HCC Risk in HCV+ - Brain Cancer
Imaging Arm of Phase I TNT Cancer Trial Completed - Breast Cancer
Study Finds No Link Between Occupation and Cancer Mortality - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
